Wikidata

(Q62809265)

English

Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

short name
Geber (English)
0 references
title
An Open-label Phase II Trial of Gefitinib and Berberine in Patients With Advanced Non-small Cell Lung Cancer and Activating EGFR Mutations (English)
0 references
start time
5 June 2018
0 references
end time
1 June 2019
0 references
number of participants
50
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62809265&oldid=2149408045"